Catalyst
Slingshot members are tracking this event:
Recro Pharma (REPH) to Submit New Drug Application to FDA in Summer 2017 for IV Meloxicam in Serious Acute Pain
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| REPH |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 31, 2017
Occurred Source:
http://ir.recropharma.com/press-releases/detail/80/recro-pharma-submits-new-drug-application-for-iv-meloxicam
Related Projects
- With another successful trial for Meloxicam in post operative pain, where could the drug fit into the treatment landscape? REPH, INSY Executed On: Dec 02, 2016 at 10:30 AM EST
Related Keywords
New Drug Application, Fda, Iv, Meloxicam, Serious Acute Pain
